NASDAQ:CSBR
Champions Oncology Stock News
$4.92
-0.1000 (-1.99%)
At Close: Apr 29, 2024
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 11, 2021
08:30am, Friday, 05'th Mar 2021
HACKENSACK, NJ / ACCESSWIRE / March 5, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider engaged in transforming drug discovery through innovative
Champions Oncology Announces Partnership with Code Ocean to Expand the Functionality of Lumin Bioinformatics
09:00am, Tuesday, 19'th Jan 2021
HACKENSACK, NJ / ACCESSWIRE / January 19, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology company that is transforming drug discovery and development through data-
HACKENSACK, NJ / ACCESSWIRE / January 5, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology company that is transforming drug discovery and development through data-dr
Champions Oncology, Inc. (CSBR) CEO Ronnie Morris on Q1 2021 Results - Earnings Call Transcript
06:20pm, Monday, 14'th Sep 2020
Champions Oncology, Inc. (NASDAQ:CSBR) Q1 2021 Earnings Conference Call September 14, 2020 04:30 PM ET Company Participants Ronnie Morris - President and CEO David Miller - Chief Financial Officer Con
Champions Oncology, Inc. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
11:21am, Thursday, 30'th Jul 2020
There's been a notable change in appetite for Champions Oncology, Inc. (NASDAQ:CSBR) shares in the week since its...
Champions Oncology Reports Quarterly Revenue of $8.8 Million
08:01pm, Monday, 27'th Jul 2020
Record Annual Revenue of $32.
Champions Oncology, Inc. (CSBR) CEO Ronnie Morris on Q4 2020 Results - Earnings Call Transcript
07:24pm, Monday, 27'th Jul 2020
Champions Oncology, Inc. (NASDAQ:CSBR) Q4 2020 Results Earnings Conference Call July 27, 2020, 4:30 pm ET Company Participants Ronnie Morris - Chief Executive Officer David Miller - Chief Financial Of
The Daily Biotech Pulse: Mixed Tidings From Novavax, Radius Health Out-licenses Breast Cancer Drug, 3 IPOs
12:00am, Friday, 24'th Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 23)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Acceleron Pharma Inc (NASDAQ: XLRN)
Aerpio...
Champions Oncology to Announce Fourth Quarter Financial Results on Monday, July 27, 2020
12:00pm, Wednesday, 22'nd Jul 2020
HACKENSACK, NJ / ACCESSWIRE / July 22, 2020 / Champions Oncology, Inc.
Make It Or Break It - Champions Oncology
12:08pm, Tuesday, 21'st Jul 2020
Champions Oncology did not report financial results for the three months ending April 2020. Lack of communication in behalf of the company puts investors in the dark regards the company operations dur
What Type Of Shareholders Own The Most Number of Champions Oncology, Inc. (NASDAQ:CSBR) Shares?
07:55pm, Wednesday, 15'th Jul 2020
The big shareholder groups in Champions Oncology, Inc. (NASDAQ:CSBR) have power over the company. Large companies...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 6)
ACADIA Pharmaceuticals Inc...
Champions Oncology (NASDAQ:CSBR) Lowered to Hold at Zacks Investment Research
03:24am, Tuesday, 30'th Jun 2020
Zacks Investment Research downgraded shares of Champions Oncology (NASDAQ:CSBR) from a buy rating to a hold rating in a report released on Friday morning, Zacks.com reports. According to Zacks, “Cha
The Global Humanized Mouse Model Market will grow by USD 74.72 mn during 2020-2024
Champions Oncology (NASDAQ:CSBR) Share Price Crosses Above Two Hundred Day Moving Average of $7.69
02:44am, Thursday, 25'th Jun 2020
Champions Oncology Inc (NASDAQ:CSBR) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $7.69 and traded as high as $9.97.
